drugset / Trial / NCT04166396

Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis

NCT04166396

Phase 0 Completed 8 enrolled Virginia Commonwealth University
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this research study is to examine if the use of antioxidant supplements impacts exercise intolerance in people with CF.

Timeline

Start
2020-02-17
Primary completion
2024-07-30
Completion
2024-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject NR Unknown 500 mg
Subject Resveratrol Small molecule 500 mg

Indications